| 000 | 01146 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250514204816.0 | ||
| 264 | 0 | _c20041207 | |
| 008 | 200412s 0 0 eng d | ||
| 022 | _a0003-4967 | ||
| 024 | 7 |
_a10.1136/ard.2004.028290 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aO'shea, J J | |
| 245 | 0 | 0 |
_aTargeting the Jak/STAT pathway for immunosuppression. _h[electronic resource] |
| 260 |
_bAnnals of the rheumatic diseases _cNov 2004 |
||
| 300 |
_aii67-ii71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCytokines _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
| 650 | 0 | 4 | _aJanus Kinase 3 |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSevere Combined Immunodeficiency _ximmunology |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aTrans-Activators _xantagonists & inhibitors |
| 773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 63 Suppl 2 _gp. ii67-ii71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/ard.2004.028290 _zAvailable from publisher's website |
| 999 |
_c15170854 _d15170854 |
||